Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |